HTRF FcRn Binding kit, 100 Assay Points

Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Australia

Austria

Belgium

Brazil *

Canada

China *

Denmark

Finland

France

Germany

Hong Kong *

India *

Ireland

Italy

Japan *

Luxembourg

Mexico *

Netherlands

Norway

Philippines *

Republic of Korea *

Singapore *

Spain

Sweden

Switzerland

Thailand *

United Kingdom

United States

HTRF FcRn Binding kit, 100 Assay Points

The FcRn binding kit is designed to monitor the binding of the IgG Fc region to the human FcRn receptor.

For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).

View product information

Feature	Specification
Application	Protein-Protein Interaction
Sample Volume	10 µL

Request More Information

The FcRn binding kit is designed to monitor the binding of the IgG Fc region to the human FcRn receptor.

View product information

Product Variants

Unit Size: 100 Assay Points

Part #:

64FCRNPET

List Price

USD 1,053.00

Unit Size: 500 Assay Points

Part #:

64FCRNPEG

List Price

USD 3,865.00

Unit Size: 10,000 Assay Points

Part #:

64FCRNPEH

List Price

USD 28,560.00

Product information

Overview

The neonatal Fc receptor is an Fc receptor found in the placenta. It displays the unique feature of facilitating IgG transport from the mother to the growing fetus. This receptor also has an important role in modulating IgG and albumin half-life in the bloodstream, influencing the pharmacokinetic parameters through an FcRn-mediated transcytosis process. The FcRn kit measures the binding between Fc-based molecules and the FcRn receptor.

Specifications

Other Specifications

Application	Protein-Protein Interaction
Brand	HTRF
Detection Modality	HTRF
Product Group	Kit
Sample Volume	10 µL
Shipping Conditions	Shipped in Dry Ice
Target Class	Binding Assay
Technology	TR-FRET
Therapeutic Area	Inflammation Neuroscience Oncology & Inflammation
Unit Size	100 Assay Points

Video gallery

How it works

Assay principle

The FcRn receptor biochemical binding assay is a competitive assay involving the extracellular ectodomain of FcRn that is biotinylated and bound to Terbium cryptate-labeled Streptavidin, and human IgG1 labelled with d2. The unlabeled antibody or Fc fused drug competes with the d2 labelled IgG1 for binding to the receptor, resulting in a decrease in FRET signal.

Assay protocol

The FcRn biochemical binding assay needs only 1 incubation step after reagent distribution. Terbium Cryptate pre-labelled FcRn ectodomain is dispensed, followed by the addition of the sample and IgG1 labelled with d2. After 2h of incubation at RT, the signal can be read.

Assay validation

FcRn binding kit species selectivity

IgG1 isotypes from human and mouse were serially diluted with the diluent buffer provided in the kit, starting from 1mg/mL. Human and Mouse IgG1 were then tested in a competition mode. The chart demonstrates that the human IgG1 antibody efficiently displaces the d2 labelled IgG1 antibody in a dose dependent manner, whereas the FRET signal remains constant when the mouse IgG1 concentration increases. These data indicate that the FcRn binding kit is human IgG specific and not compatible with other IgG species.

Inhibitory effect of Rituximab and Pembrolizumab antibodies

The inhibitory effects of two FDA approved antibodies, anti-CD20 Rituximab and the anti-PD1 Pembrolizumab, were investigated with the FcRn binding kit. The anti-CD20 IgG1 Rituximab and the anti-PD1 IgG4 Pembrolizumab were serially diluted with the diluent buffer provided in the kit, starting from 1 mg/mL and tested in a competition dose response. The data presented in the graph show that both antibodies efficiently compete with the d2-labelled antibody in a dose-dependent manner, and display similar IC50. The results show that the kit is compatible with human IgG1 and IgG4 antibodies.